E-cigarettes:Threat or opportunity? by Gilmore, A. B. & Hartwell, G.
        
Citation for published version:
Gilmore, AB & Hartwell, G 2014, 'E-cigarettes: Threat or opportunity?', European Journal of Public Health, vol.
24, no. 4, pp. 532-533. https://doi.org/10.1093/eurpub/cku085
DOI:
10.1093/eurpub/cku085
Publication date:
2014
Document Version
Peer reviewed version
Link to publication
This is a pre-copyedited, author-produced PDF of an article accepted for publication in European Journal of
Public Health following peer review. The version of record, Gilmore, AB & Hartwell, G 2014, 'E-cigarettes: threat
or opportunity?: Threat or opportunity?' European Journal of Public Health, vol 24, no. 4, pp. 532-533., is
available online at: http://dx.doi.org/10.1093/eurpub/cku085.
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. May. 2019
E-CIGARETTES: THREAT OR OPPORTUNITY?  
Anna B Gilmore (1) 
Greg Hartwell (2) 
 
(1) Corresponding author: Anna B Gilmore, Department of Health and UK Centre for 
Tobacco and Alcohol Studies (UKCTAS) University of Bath, Claverton Down, Bath 
BA2 7AY. A.gilmore@bath.ac.uk 
(2) Greg Hartwell, School for Public Health Research, London School of Hygiene and 
Tropical Medicine, Tavistock Place, London WC1H 9SH 
 
1027 words 
 
 
Two contrasting Viewpoints by Stimson and Chapman in this edition illustrate the divisions 
in the public health community over e-cigarettes. Stimson argues that we should embrace 
and promote e-cigarettes, while Chapman highlights the pitfalls of this simplistic approach.  
Such contrasting views are perhaps inevitable given the infant evidence base surrounding 
this rapidly emerging technology, but the consequent uncertainty about the population 
impacts of e-cigarettes should preclude an overly firm stance either for or against – as we 
outline below, it is simply too early to know.  
 
Two key questions surround this debate: are e-cigarettes an opportunity or threat to public 
health and how can we ensure benefits are maximised and harms minimised?  As Michael 
Russell wrote in 1976, “people smoke for the nicotine but they die from the tar.”  E-
cigarettes deliver the nicotine without the tar as their use involves no tobacco combustion. 
Common sense therefore dictates that e-cigarettes are significantly less harmful than 
cigarettes and for the individual smoker there is little doubt that switching to e-cigarettes 
will be beneficial.  
 
The population level impacts, however, are far less certain. If taken up only by smokers or 
those who would otherwise have taken up smoking and if effective as a cessation aid, e-
cigarettes will undoubtedly be a force for good. Conversely, if the heavy marketing of e-
cigarettes which has been found to target young people through adverts uncannily similar 
to cigarette ads long ago banished from our screens, and their use in smoke-free public 
places re-normalise and re-glamorise smoking thereby threatening progress in tobacco 
control, lead into rather than out of smoking (the so-called gateway effect), and maintain 
addiction rather than promoting cessation, they may be detrimental to public health. 
Ultimately, the balance between these various potential outcomes and the health impacts 
of e-cigarettes   will determine the extent of any public health gain. 
 
These are all issues on which we know relatively little. The remarkable speed of uptake 
shows e-cigarettes are acceptable to smokers in a way that medicinal nicotine products are 
not, suggesting they could replace smoking.  Yet their efficacy as quit aids remains 
uncertain. While dedicated users report that e-cigarettes helped them quit smoking, these 
benefits are not seen in population based cross-sectional surveys.(1) Longitudinal data are 
either flawed(2) or find no significant impact on quitting,(3, 4) while randomised controlled 
trials find e-cigarettes are no more effective than nicotine patches in achieving smoking 
cessation.(5, 6) The Smoking Toolkit Study, monthly repeat cross-sectional surveys 
representative of the English population, provides the most supportive data showing that 
those using e-cigarettes to quit were significantly more likely to succeed than those using 
over-the-counter nicotine replacement.(7) The data also suggest e-cigarettes may be 
contributing to a reduction in smoking prevalence in England through increased quit 
attempts and success.(8, 9) 
 
Despite consensus on the health benefits of e-cigarettes relative to cigarettes, little is known 
about their absolute health impacts.  No studies have examined long-term impacts including 
those of inhaled humectants (the main e-liquid ingredient), flavourings or additives.(1, 10) 
Yet e-cigarette vapour has been found to contain a variety of toxic and carcinogenic 
chemicals albeit, initial studies suggested, at considerably lower levels than in cigarette 
smoke.(11, 12) Recent work, however, finds that concentrations may reach levels seen in 
cigarette smoke(13) while in-vitro studies find varying levels of cytotoxicity.(1, 14, 15) 
 
Despite concerns about uptake among young non-smokers, no longitudinal studies have yet 
examined whether e-cigarettes serve as ‘gateways’ to future tobacco use, though it is 
reassuring that in all studies, including those in young people(16), the majority of users are 
current or former smokers(1).  Nonetheless, while surveys show negligible use among young 
non-smokers in the UK (2013 data), elsewhere in Europe – including France, Poland, Finland 
and Hungary(17-20) – e-cigarette use among young non-smokers is reported as ranging 
from 3.2% to 4.7%(16). Repeat cross-sectional data from the US also show increasing rates 
of youth e-cigarette use(16).  
 
The transnational tobacco companies’ (TTCs) growing involvement in e-cigarettes is a 
further concern. TTCs’ own documents show their historical interest in harm reduction was 
driven by the potential to prevent rather than encourage declines in smoking, to enhance 
their tarnished reputation and to enable access public health groups and policy makers(21, 
22), the latter a particular concern when TTCs have increasingly being driven from the 
policy-making table. TTCs are already actively using harm reduction rhetoric to undermine 
the authority of public health organisations, while e-cig adverts have been used to 
undermine smokefree policies and effectively promote smoking given the marked similarity 
between cigarettes and e-cigarettes at a time when other marketing routes are being 
rapidly closed. 
 
We turn then to our second question – how best to maximise opportunities and minimise 
harms?  This requires research and timely monitoring of trends so that adverse 
developments can be quickly addressed. It also requires a regulatory framework that 
encourages e-cigarette uptake among current smokers and innovation to maximise 
effectiveness as a quit product while simultaneously maximising product safety and 
preventing uptake among non-smokers. Such aims may be mutually exclusive as reflected in 
heated debates over the 2014 EU Tobacco Products Directive which reached a compromise 
in requiring products to be licenced either as medicines with related limitations on 
marketing, or as consumer products subject to quality and purity standards and the same 
advertising restrictions as tobacco. However, the TPD only comes into force in 2016 and 
much can happen in the interim. Member States may, therefore, wish to further protect 
non-smokers through controls on marketing and use in public places(23), the latter being 
implemented in some US states by bringing e-cigarettes under the auspices of smokefree 
regulations.  
 Above all we must not allow e-cigarettes to detract attention from what should be our key 
focus – smoked tobacco. Policies on e-cigarettes must therefore be combined with those 
making tobacco even less desirable and available. Indeed, we believe e-cigarettes present a 
unique opportunity to take a more radical approach and phase out combustible tobacco 
use. If e-cigarettes really do enable quitting, if tobacco companies really are committed to 
harm reduction and if changes are phased in, giving companies and users time to adjust, 
there should be little objection. Such an approach would eliminate the threats identified 
above and save far more lives. 
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